ArticleClinical and experimental medicine2025

N6-methyladenosine-mediated upregulation of H19 promotes resistance to bortezomib by modulating the miR-184/CARM1 axis in multiple myeloma.

Gang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.